Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy (original) (raw)

• Cohen, O.J. & Fauci, A.S. Current strategies in the treatment of HIV infection. Adv. Intern. Med. 46, 207–246 (2001).
  CAS PubMed Google Scholar
• Hazuda, D.J. et al. Inhibitors of strand transfer that prevent integration and inhibit HIV- 1 replication in cells. Science 287, 646–650 (2000).
  CAS PubMed Google Scholar
• Bieniasz, P.D. & Cullen, B.R. Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J. Virol. 74, 9868–9877 (2000).
  CAS PubMed PubMed Central Google Scholar
• Mariani, R. et al. A block to human immunodeficiency virus type 1 assembly in murine cells. J. Virol. 74, 3859–3870 (2000).
  CAS PubMed PubMed Central Google Scholar
• Garber, M.E. et al. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12, 3512–3527 (1998).
  CAS PubMed PubMed Central Google Scholar
• Taube, R., Fujinaga, K., Wimmer, J., Barboric, M. & Peterlin, B.M. Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation. Virology 264, 245–253 (1999).
  CAS PubMed Google Scholar
• Cullen, B.R. Retroviruses as model systems for the study of nuclear RNA export pathways. Virology 249, 203–210 (1998).
  CAS PubMed Google Scholar
• Doms, R.W. & Trono, D. The plasma membrane as a combat zone in the HIV battlefield. Genes Dev. 14, 2677–2688 (2000).
  CAS PubMed Google Scholar
• Chan, D.C. & Kim, P.S. HIV entry and its inhibition. Cell 93, 681–684 (1998).
  CAS PubMed Google Scholar
• Nguyen, D.H. & Hildreth, J.E. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 74, 3264–3272 (2000).
  CAS PubMed PubMed Central Google Scholar
• Campbell, S.M., Crowe, S.M. & Mak, J. Lipid rafts and HIV-1: from viral entry to assembly of progeny virions. J. Clin. Virol. 22, 217–227 (2001).
  CAS PubMed Google Scholar
• Kwong, P.D. et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648–659 (1998).
  CAS PubMed PubMed Central Google Scholar
• Scarlatti, G. et al. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nature Med. 3, 1259–1265 (1997).
  Article CAS PubMed Google Scholar
• Liu, R. et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367–377 (1996).
  CAS PubMed Google Scholar
• Martinson, J.J., Chapman, N.H., Rees, D.C., Liu, Y.T. & Clegg, J.B. Global distribution of the CCR5 gene 32-basepair deletion. Nature Genet. 16, 100–103 (1997).
  CAS PubMed Google Scholar
• Kozak, S.L., Heard, J.M. & Kabat, D. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus. J. Virol. 76, 1802–1815 (2002).
  CAS PubMed PubMed Central Google Scholar
• Liao, Z., Cimakasky, L.M., Hampton, R., Nguyen, D.H. & Hildreth, J.E. Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res. Hum. Retroviruses 17, 1009–1019 (2001).
  CAS PubMed Google Scholar
• Geijtenbeek, T.B. et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100, 587–597 (2000).
  CAS PubMed Google Scholar
• Kwon, D.S., Gregorio, G., Bitton, N., Hendrickson, W.A. & Littman, D.R. DC-SIGN-mediated internalization of HIV is required for trans- enhancement of T cell infection. Immunity 16, 135–144 (2002).
  CAS PubMed Google Scholar
• Skehel, J.J. & Wiley, D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69, 531–569 (2000).
  CAS PubMed Google Scholar
• Fackler, O.T. & Peterlin, B.M. Endocytic entry of HIV-1. Curr. Biol. 10, 1005–1008 (2000).
  CAS PubMed Google Scholar
• Cartier, C. et al. Identification of three major phosphorylation sites within HIV-1 capsid. Role of phosphorylation during the early steps of infection. J. Biol. Chem. 274, 19434–19440 (1999).
  CAS PubMed Google Scholar
• Franke, E.K., Yuan, H.E. & Luban, J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372, 359–362 (1994).
  CAS PubMed Google Scholar
• Schaeffer, E., Geleziunas, R. & Greene, W.C. Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions. J. Virol. 75, 2993–3000 (2001).
  CAS PubMed PubMed Central Google Scholar
• Ohagen, A. & Gabuzda, D. Role of Vif in stability of the human immunodeficiency virus type 1 core. J. Virol. 74, 11055–11066 (2000).
  CAS PubMed PubMed Central Google Scholar
• Lu, X., Yu, H., Liu, S.H., Brodsky, F.M. & Peterlin, B.M. Interactions between HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4. Immunity 8, 647–656 (1998).
  CAS PubMed Google Scholar
• Takeda, M., Pekosz, A., Shuck, K., Pinto, L.H. & Lamb, R.A. Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture. J. Virol. 76, 1391–1399 (2002).
  CAS PubMed PubMed Central Google Scholar
• Karageorgos, L., Li, P. & Burrell, C. Characterization of HIV replication complexes early after cell-to-cell infection. AIDS Res. Hum. Retroviruses 9, 817–823 (1993).
  CAS PubMed Google Scholar
• Bukrinskaya, A., Brichacek, B., Mann, A. & Stevenson, M. Establishment of a functional human immunodeficiency virus type 1 (HIV- 1) reverse transcription complex involves the cytoskeleton. J. Exp. Med. 188, 2113–2125 (1998).
  CAS PubMed PubMed Central Google Scholar
• Simon, J.H., Gaddis, N.C., Fouchier, R.A. & Malim, M.H. Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nature Med. 4, 1397–1400 (1998).
  CAS PubMed Google Scholar
• Miller, M.D., Farnet, C.M. & Bushman, F.D. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J. Virol. 71, 5382–5390 (1997).
  CAS PubMed PubMed Central Google Scholar
• Bell, P., Montaner, L.J. & Maul, G.G. Accumulation and intranuclear distribution of unintegrated human immunodeficiency virus type 1 DNA. J. Virol. 75, 7683–7691 (2001).
  CAS PubMed PubMed Central Google Scholar
• Turelli, P. et al. Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol. Cell 7, 1245–1254 (2001).
  CAS PubMed Google Scholar
• Weinberg, J.B., Matthews, T.J., Cullen, B.R. & Malim, M.H. Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J. Exp. Med. 174, 1477–1482 (1991).
  CAS PubMed Google Scholar
• Pemberton, L.F., Blobel, G. & Rosenblum, J.S. Transport routes through the nuclear pore complex. Curr. Opin Cell Biol. 10, 392–399 (1998).
  CAS PubMed Google Scholar
• Gallay, P., Hope, T., Chin, D. & Trono, D. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl. Acad. Sci. USA 94, 9825–9830 (1997).
  CAS PubMed PubMed Central Google Scholar
• Bukrinsky, M.I. et al. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365, 666–669 (1993).
  CAS PubMed Google Scholar
• Heinzinger, N.K. et al. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91, 7311–7315 (1994).
  CAS PubMed PubMed Central Google Scholar
• Zennou, V. et al. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101, 173–185 (2000).
  CAS PubMed Google Scholar
• Sherman, M.P., de Noronha, C.M., Heusch, M.I., Greene, S. & Greene, W.C. Nucleocytoplasmic shuttling by human immunodeficiency virus type 1 Vpr. J. Virol. 75, 1522–1532 (2001).
  CAS PubMed PubMed Central Google Scholar
• Eckstein, D.A. et al. HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells. J. Exp. Med. 194, 1407–1419 (2001).
  CAS PubMed PubMed Central Google Scholar
• Vodicka, M.A., Koepp, D.M., Silver, P.A. & Emerman, M. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev. 12, 175–185 (1998).
  CAS PubMed PubMed Central Google Scholar
• Dupont, S. et al. A novel nuclear export activity in HIV-1 matrix protein required for viral replication. Nature 402, 681–685 (1999).
  CAS PubMed Google Scholar
• Chen, H. & Engelman, A. The barrier-to-autointegration protein is a host factor for HIV type 1 integration. Proc. Natl. Acad. Sci. USA 95, 15270–4 (1998).
  CAS PubMed PubMed Central Google Scholar
• Wu, Y. & Marsh, J.W. Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science 293, 1503–1506 (2001).
  CAS PubMed Google Scholar
• Li, L. et al. Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection. EMBO J. 20, 3272–3281 (2001).
  CAS PubMed PubMed Central Google Scholar
• Adams, M. et al. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter- proximal transcripts. Proc. Natl. Acad. Sci. USA 91, 3862–3866 (1994).
  CAS PubMed PubMed Central Google Scholar
• Jordan, A., Defechereux, P. & Verdin, E. The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J. 20, 1726–1738 (2001).
  CAS PubMed PubMed Central Google Scholar
• Kao, S.Y., Calman, A.F., Luciw, P.A. & Peterlin, B.M. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 330, 489–493 (1987).
  CAS PubMed Google Scholar
• Jones, K.A. & Peterlin, B.M. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63, 717–743 (1994).
  CAS PubMed Google Scholar
• Karin, M. & Ben-Neriah, Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol 18, 621–663 (2000).
  CAS PubMed Google Scholar
• Crabtree, G.R. Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. Cell 96, 611–614 (1999).
  CAS PubMed Google Scholar
• Barboric, M., Nissen, R.M., Kanazawa, S., Jabrane-Ferrat, N. & Peterlin, B.M. NF-κB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell 8, 327–337 (2001).
  CAS PubMed Google Scholar
• Wei, P., Garber, M.E., Fang, S.M., Fischer, W.H. & Jones, K.A. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92, 451–462 (1998).
  CAS PubMed Google Scholar
• Price, D.H. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell Biol. 20, 2629–2634 (2000).
  CAS PubMed PubMed Central Google Scholar
• Garber, M.E. et al. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 Tat-P-TEFb complex to TAR RNA. Mol. Cell Biol. 20, 6958–6969 (2000).
  CAS PubMed PubMed Central Google Scholar
• Yang, Z., Zhu, Q., Luo, K. & Zhou, Q. The 7SK small nuclear RNA inhibits the CDK9/cy_Clin_. T1 kinase to control transcription. Nature 414, 317–322 (2001).
  CAS PubMed Google Scholar
• Powell, D.M., Amaral, M.C., Wu, J.Y., Maniatis, T. & Greene, W.C. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing. Proc. Natl. Acad. Sci. USA 94, 973–978 (1997).
  CAS PubMed PubMed Central Google Scholar
• Luo, Y., Yu, H. & Peterlin, B.M. Cellular protein modulates effects of human immunodeficiency virus type 1 Rev. J. Virol. 68, 3850–3856 (1994).
  CAS PubMed PubMed Central Google Scholar
• Malim, M.H. et al. HIV-1 structural gene expression requires. binding of the Rev. trans- activator to its RNA target sequence. Cell 60, 675–683 (1990).
  CAS PubMed Google Scholar
• Malim, M.H. & Cullen, B.R. Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes. Mol. Cell Biol. 13, 6180–6189 (1993).
  CAS PubMed PubMed Central Google Scholar
• Khan, I.H. et al. Role of the SH3-ligand domain of simian immunodeficiency virus Nef in interaction with Nef-associated kinase and simian AIDS in rhesus macaques. J. Virol. 72, 5820–5830 (1998).
  CAS PubMed PubMed Central Google Scholar
• Simmons, A., Aluvihare, V. & McMichael, A. Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. Immunity 14, 763–777 (2001).
  CAS PubMed Google Scholar
• Glushakova, S. et al. CD4 down-modulation by human immunodeficiency virus type 1 Nef correlates with the efficiency of viral replication and with CD4(+) T– cell depletion in human lymphoid tissue ex vivo. J. Virol. 75, 10113–10117 (2001).
  CAS PubMed PubMed Central Google Scholar
• Lama, J., Mangasarian, A. & Trono, D. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Curr. Biol. 9, 622–631 (1999).
  CAS PubMed Google Scholar
• Zheng, Y.H., Plemenitas, A., Linnemann, T., Fackler, O.T. & Peterlin, B.M. Nef increases infectivity of HIV via lipid rafts. Curr. Biol. 11, 875–879 (2001).
  CAS PubMed Google Scholar
• Geyer, M., Fackler, O.T. & Peterlin, B.M. Structure–function relationships in HIV-1 Nef. EMBO Rep. 2, 580–585 (2001).
  CAS PubMed PubMed Central Google Scholar
• Wang, J.K., Kiyokawa, E., Verdin, E. & Trono, D. The Nef protein of HIV-1 associates with rafts and primes T cells for activation. Proc. Natl. Acad. Sci. USA 97, 394–399 (2000).
  CAS PubMed PubMed Central Google Scholar
• Chen, B.K., Gandhi, R.T. & Baltimore, D. CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef. J. Virol. 70, 6044–6053 (1996).
  CAS PubMed PubMed Central Google Scholar
• Crise, B., Buonocore, L. & Rose, J.K. CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor. J. Virol. 64, 5585–5593 (1990).
  CAS PubMed PubMed Central Google Scholar
• Margottin, F. et al. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1, 565–574 (1998).
  CAS PubMed Google Scholar
• Xu, X.N. et al. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J. Exp. Med. 189, 1489–1496 (1999).
  CAS PubMed PubMed Central Google Scholar
• Collins, K.L., Chen, B.K., Kalams, S.A., Walker, B.D. & Baltimore, D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397–401 (1998).
  CAS PubMed Google Scholar
• Le Gall, S. et al. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8, 483–495 (1998).
  CAS PubMed Google Scholar
• Geleziunas, R., Xu, W., Takeda, K., Ichijo, H. & Greene, W.C. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature 410, 834–838 (2001).
  CAS PubMed Google Scholar
• Wolf, D. et al. HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad- phosphorylation to induce anti-apoptotic signals. Nature Med. 7, 1217–1224 (2001).
  CAS PubMed Google Scholar
• Greenway, A.L. et al. Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis. J. Virol. 76, 2692–2702 (2002).
  CAS PubMed PubMed Central Google Scholar
• Jowett, J.B. et al. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol. 69, 6304–6313 (1995).
  CAS PubMed PubMed Central Google Scholar
• Goh, W.C. et al. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nature Med. 4, 65–71 (1998).
  CAS PubMed Google Scholar
• de Noronha, C.M. et al. Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr. Science 294, 1105–1108 (2001).
  CAS PubMed Google Scholar
• Freed, E.O. HIV-1 gag proteins: diverse functions in the virus life cycle. Virology 251, 1–15 (1998).
  CAS PubMed Google Scholar
• Wilk, T. et al. Organization of immature human immunodeficiency virus type 1. J. Virol. 75, 759–771 (2001).
  CAS PubMed PubMed Central Google Scholar
• Zimmerman, C. et al. Identification of a host protein essential for assembly of immature HIV- 1 capsids. Nature 415, 88–92 (2002).
  CAS PubMed Google Scholar
• Gottlinger, H.G., Sodroski, J.G. & Haseltine, W.A. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86, 5781–5785 (1989).
  CAS PubMed PubMed Central Google Scholar
• Ono, A. & Freed, E.O. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. USA 98, 13925–13930 (2001).
  CAS PubMed PubMed Central Google Scholar
• Garnier, L., Parent, L.J., Rovinski, B., Cao, S.X. & Wills, J.W. Identification of retroviral late domains as determinants of particle size. J. Virol. 73, 2309–2320 (1999).
  CAS PubMed PubMed Central Google Scholar
• Strack, B., Calistri, A., Accola, M.A., Palu, G. & Gottlinger, H.G. A role for ubiquitin ligase recruitment in retrovirus release. Proc. Natl. Acad. Sci. USA 97, 13063–13068 (2000).
  CAS PubMed PubMed Central Google Scholar
• Garrus, J.E. et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107, 55–65 (2001).
  CAS PubMed Google Scholar
• VerPlank, L. et al. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc. Natl. Acad. Sci. USA 98, 7724–7729 (2001).
  CAS PubMed PubMed Central Google Scholar
• Katzmann, D.J., Babst, M. & Emr, S.D. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell 106, 145–155 (2001).
  CAS PubMed Google Scholar
• Finkel, T.H. et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med. 1, 129–134 (1995).
  CAS PubMed Google Scholar
• Kowalski, M. et al. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237, 1351–1355 (1987).
  CAS PubMed Google Scholar
• Westendorp, M.O. et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375, 497–500 (1995).
  CAS PubMed Google Scholar
• Baur, A.S. et al. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1, 373–384 (1994).
  CAS PubMed Google Scholar
• Stewart, S.A., Poon, B., Jowett, J.B. & Chen, I.S. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J. Virol. 71, 5579–5592 (1997).
  CAS PubMed PubMed Central Google Scholar
• Somasundaran, M. & Robinson, H.L. Unexpectedly high levels of HIV-1 RNA and protein synthesis in a cytocidal infection. Science 242, 1554–1557 (1988).
  CAS PubMed Google Scholar
• Hanna, Z. et al. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95, 163–175 (1998).
  CAS PubMed Google Scholar
• Chao, S.H. et al. Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. J. Biol. Chem. 275, 28345–28348 (2000).
  CAS PubMed Google Scholar
• Lind, K.E., Du, Z., Fujinaga, K., Peterlin, B.M. & James, T.L. Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA. Chem. Biol. 9, 185–193 (2002).
  CAS PubMed Google Scholar
• Wolff, B., Sanglier, J.J. & Wang, Y. Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo- cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem. Biol. 4, 139–147 (1997).
  CAS PubMed Google Scholar